The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vybornykh D.E.

National Medical Research Center for Hematology

Ivanov S.V.

Mental Health Research Center

Gemdzhian E.G.

National Medical Research Center for Hematology

Gaponova T.V.

National Medical Research Center for Hematology

Psychopharmacotherapy of mental disorders in hematological patients: security concerns

Authors:

Vybornykh D.E., Ivanov S.V., Gemdzhian E.G., Gaponova T.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4‑2): 90‑98

DOI: 10.17116/jnevro202312304290

Read: 4262 times

Download PDF (RU)
Contact the author
Table of contents

PSYCHOPHARMACOTHERAPY OF MENTAL DISORDERS IN HEMATOLOGICAL PATIENTS: SECURITY CONCERNS
PSYCHOPHARMACOTHERAPY OF MENTAL DISORDERS IN HEMATOLOGICAL PATIENTS: SECURITY CONCERNS

To cite this article:

Vybornykh DE, Ivanov SV, Gemdzhian EG, Gaponova TV. Psychopharmacotherapy of mental disorders in hematological patients: security concerns. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4‑2):90‑98. (In Russ.)
https://doi.org/10.17116/jnevro202312304290

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Resu­lts of the inte­rnational multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the effi­cacy and safety of the sequential therapy with ethy­lmethylhydroxypyridine succinate in patients in the acute and early reco­very periods of ischemic stroke (MIR). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):40-53
Effi­cacy and safety of topi­cal anti­biotic therapy in patients with acute exte­rnal bacterial otitis: resu­lts of a retrospective study. Russian Bulletin of Otorhinolaryngology. 2024;(6):24-27
Open obse­rvational study with a retrospective analysis of the effi­cacy and tole­rability of aceclofenac in patients with acute non-specific low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):99-105
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Perioperative complications of sple­nectomy in hema­tological patients. Endo­scopic Surgery. 2025;(2):56-64
Expe­rience of using ribo­ciclib in the therapy of meta­static breast cancer in a regional onco­logical dispensary. P.A. Herzen Journal of Onco­logy. 2025;(3):89-93
Hysterical diso­rders in patients with hema­tological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):71-78
Resu­lts of an open-label, randomized, multicenter, comparative study of clinical effi­cacy and safety of Pulmibud drug and Pulmicort drug in patients with partially controlled and unco­ntrolled persistent bronchial asthma. Journal of Respiratory Medi­cine. 2025;(3):33-38
Abstract:

OBJECTIVE

Evaluation of the safety of psychopharmacotherapy (PFT) of mental disorders in modern protocols for the treatment of patients with blood disorders.

MATERIAL AND METHODS

The data of medical records of 552 patients with blood disorders who received PFT during treatment at the clinic of the National Medical Research Center for Hematology were analyzed. Any adverse events recorded while taking PFT were taken into account. Statistical analysis included descriptive statistics, frequency analysis, and assessment (Student’s t-test) of changes in blood parameters (before and after taking psychotropic drugs).

RESULTS

Signs of hematotoxicity were found only in 7.1% (n=37) patients, in all cases while taking benzodiazepines (n=12) in combination with hematotoxic drugs for the treatment of blood disorders. Other significant adverse events (which caused premature discontinuation or dose reduction) were detected in 4.8% (n=25) cases, of which 9 were associated with the appointment of anxiolytics (hydroxyzine, zopiclone), 11 with antidepressants (clomipramine, amitriptyline, duloxetine, trazodone, ademethionine) and 5 with antipsychotics (risperidone, alimemazine, haloperidol).

CONCLUSION

Most psychotropic drugs are effective in relation to psychopathological disorders that develop in hematological patients and are safe when used at minimum/average therapeutic doses within the daily dosage ranges established by the official instructions for use.

Keywords:

diseases of the blood system
psychotropic drugs
hematotoxicity
safety

Authors:

Vybornykh D.E.

National Medical Research Center for Hematology

Ivanov S.V.

Mental Health Research Center

Gemdzhian E.G.

National Medical Research Center for Hematology

Gaponova T.V.

National Medical Research Center for Hematology

Received:

21.11.2022

Accepted:

05.12.2022

Close metadata

References:

  1. Malignant neoplasms In Russia in 2020 (morbidity and mortality). Edited by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. M.: MNIOI im. P.A. Herzen; 2021;252. (In Russ.).
  2. Vybornykh DE. Clinical and epidemiological study of a sample of patients with diseases of the blood system. Konsul’tativnaja Psihologija i Psihoterapija. 2014;1(80):64-89. (In Russ.).
  3. Ivanov SV, Voronova EI. Depression therapy for somatic diseases. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(5-2):106-112. (In Russ.). https://doi.org/10.17116/jnevro2021121052106
  4. Vybornykh D.E. Effect of psychotropic drugs on the hematopoietic system. Social’naja i Klinicheskaja Psihiatrija. 2002;12(4):71-79. (In Russ.).
  5. Balon R, Berchou R. Hematologic side effects of psychotropic drugs. Psychosomatics. 1986;27(2):119-120, 125-127.  https://doi.org/10.1016/S0033-3182(86)72722-9
  6. Brusov OS, Karpova NS, Factor MI, et al. Decreased procoagulant activity of blood plasma in patients with schizophrenia during pharmacotherapy: thrombodynamic parameters of coagulation before and after treatment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(10):51-55. (In Russ.). https://doi.org/10.17116/jnevro201911910151
  7. Mazaira S. Efectos adversos hematológicos de los psicofármacos [Haematological adverse effects caused by psychiatric drugs]. Vertex. 2008;19(82):378-386. 
  8. Garcia-Rosa S, Carvalho BS, Guest PC, et al. Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients. J Proteomics. 2020;224:103813. https://doi.org/10.1016/j.jprot.2020.103813
  9. Vidal Handbook 2022. Medicines In Russia. Vidal Rus; 2022;1120. (In Russ.).
  10. Sirota P, Stoler M, Meshulam B. Major depression with psychotic features associated with acyclovir therapy. Drug Intell Clin Pharm. 1988;4(22):306-308. 
  11. Dixon D, Craven J. Continuous infusion of haloperidol. Am J Psychiatry. 1993;150(4):673.  https://doi.org/10.1176/ajp.150.4.673a
  12. Michopoulos I, Christodoulou C, Dervenoulas J, et al. Quetiapine monotherapy in bipolar I disorder: a 1-year stabilization in a woman having undergone bone marrow transplantation. World J Biol Psychiatry. 2010;11:519-521.  https://doi.org/10.3109/15622970701624587
  13. Slaughter JR, Jain A, Holmes S, et al. Panic disorder in hospitalized cancer patients. Psychooncology. 2000;9(3):253-258.  https://doi.org/10.1002/1099-1611(200005/06)9:3<253::aid-pon449>3.0.co;2-c
  14. Ito M, Onose M, Yamada T, et al. Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: a case report. Jpn J Clin Oncol. 2003;33(10):538-540.  https://doi.org/10.1093/jjco/hyg097
  15. Ambanelli U, Manganelli P. Sifnificato clinico delle alterazioni del metabolismo del triptofano [Clinical significance of changes in tryptophan metabolism]. Ateneo Parmense Acta Biomed. 1975;46(1-2):5-19. 
  16. Goodman AB. Medical conditions in Ashkenazi schizophrenic pedigrees. Schizophr Bull. 1994;20(3):507-517.  https://doi.org/10.1093/schbul/20.3.507
  17. Schröder A, Weise K. Ein 20-jähriger Schizophrener mit akuter Leukämie [A 20-year-old schizophrenic patient with acute leukemia]. Psychiatr Prax. 1996;23(3):145. 
  18. Chamberlain FE, Walsh N, Falkowski J. Chemotherapy for Hodgkin’s lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005. B J Psych Bull. 2015;39(6):305-307.  https://doi.org/10.1192/pb.bp.114.048306
  19. Greenberg DR, Khandwala YS, Lu Y, et al. Disease burden in offspring is associated with changing paternal demographics in the United States. Andrology. 2020;8(2):342-347.  https://doi.org/10.1111/andr.12700
  20. Augustin NB, Maroules M. Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia. Leuk Res Rep. 2021;15:100253. https://doi.org/10.1016/j.lrr.2021.100253
  21. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat. 2001;70(1):1-10.  https://doi.org/10.1023/a:1012518831494
  22. Nazarenko GI, Kishkun AA. Clinical evaluation of laboratory results. M., 2005. (In Russ.).
  23. Sanabria E, Cuenca RE, Esteso MÁ, Maldonado M. Benzodiazepines: Their Use either as Essential Medicines or as Toxics Substances. Toxics. 2021;9(2):25.  https://doi.org/10.3390/toxics9020025
  24. Gylvin SH, Jørgensen CC, Fink-Jensen A, et al. Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty. Transfusion. 2017;57(4):971-976.  https://doi.org/10.1111/trf.13992
  25. Lopez-Vilchez I, Jerez-Dolz D, Diaz-Ricart M, et al. Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling Pathways. Thromb Haemost. 2017;117(12):2312-2321.
  26. Smith MM, Smith BB, Lahr BD, et al. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients. Anesth Analg. 2018;126(6):1859-1866. https://doi.org/10.1213/ANE.0000000000002668
  27. Belay ES, Penrose CT, Ryan SP, et al. Perioperative Selective Serotonin Reuptake Inhibitor Use Is Associated With an Increased Risk of Transfusion in Total Hip and Knee Arthroplasty. J Arthroplasty. 2019;34(12):2898-2902. https://doi.org/10.1016/j.arth.2019.04.057
  28. Kraglund KL, Mortensen JK, Johnsen SP, et al. Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study. Sci Rep. 2019;9(1):20048. https://doi.org/10.1038/s41598-019-56487-8
  29. Mawardi G, Markman TM, Muslem R, et al. SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients. Heart Lung Circ. 2020;29(8):1241-1246. https://doi.org/10.1016/j.hlc.2019.07.011
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.